James Mullen
Director/Board Member bei THERMO FISHER SCIENTIFIC
Vermögen: 2 Mio $ am 31.03.2024
Profil
James C. Mullen ist ein Geschäftsmann, der an der Spitze von 11 verschiedenen Unternehmen gestanden hat und derzeit die Position des Non-Executive Chairman bei Percivia LLC, Chairman, President & Chief Executive Officer von Editas Medicine, Inc. und Chief Executive Officer für DPx Holdings BV innehat. Er ist außerdem im Vorstand von Thermo Fisher Scientific, Inc. und The Rivers School Corp. sowie Mitglied des Biomedical Sciences Careers Program, Inc. In der Vergangenheit hatte James C. Mullen die Position des Executive Chairman bei Vicarius Pharma AG, President, Chief Executive Officer & Director bei Biogen, Inc. Direktor bei Biogen Idec, Inc. (North Carolina) und Präsident bei Biogen Idec New Ventures, Inc. (beides sind Tochtergesellschaften von Biogen, Inc.), Chairman bei Torque Therapeutics, Inc, Chief Executive Officer & Non-Independent Director bei Patheon, Inc, Chief Executive Officer & Executive Director bei Patheon NV, Principal bei GlaxoSmithKline LLC und Chairman für Biotechnology Innovation Organization. Er erhielt einen MBA von der Villanova University und einen Bachelor-Abschluss vom Rensselaer Polytechnic Institute.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.05.2023 | 2 489 ( 0,00% ) | 1 Mio $ | 31.03.2024 | |
EDITAS MEDICINE, INC.
0,09% | 04.04.2023 | 75 898 ( 0,09% ) | 563 163 $ | 31.03.2024 |
Aktive Positionen von James Mullen
| Unternehmen | Position | Beginn |
|---|---|---|
| THERMO FISHER SCIENTIFIC | Director/Board Member | 07.11.2018 |
DPx Holdings BV
 DPx Holdings BV Drugstore ChainsRetail Trade DPx Holdings BV provides pharmaceutical services, fine chemicals and proprietary products and technologies. It operates business through three business unites which include Patheon, DSM Fine Chemicals and Banner Life Sciences. Patheon consists of pharmaceutical services, which include commercial manufacturing capabilities, pharmaceutical development services, as well as the biologics and biosolutions businesses; DSM Fine Chemicals includes active pharmaceutical ingredients services as well as the ES/IM business offer is primarily comprised of agricultural and crop protection chemicals and specialty intermediates; and Banner Life Sciences serves the needs of the proprietary products business and will now include additional brands from DPP. The company has offices in Australia, Europe, Latin America and North America. DPx Holdings was founded in March 2014 and is headquartered in Framingham, MA. | Chief Executive Officer | - |
| The Rivers School Corp. | Director/Board Member | - |
Percivia LLC
 Percivia LLC Miscellaneous Commercial ServicesCommercial Services Percivia LLC engages in the research and development of vaccine and recombinant protein products. The company was founded in 2006 and is headquartered in Cambridge, MA. | Chairman | - |
| Biomedical Sciences Careers Program, Inc. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von James Mullen
| Unternehmen | Position | Ende |
|---|---|---|
| EDITAS MEDICINE, INC. | Chief Executive Officer | 01.06.2022 |
| INSULET CORPORATION | Director/Board Member | 28.01.2019 |
Torque Therapeutics, Inc.
 Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA. | Chairman | 25.01.2019 |
| PATHEON N.V. | Chief Executive Officer | 29.08.2017 |
| ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von James Mullen
| Rensselaer Polytechnic Institute | Undergraduate Degree |
| Villanova University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| BIOGEN INC. | Health Technology |
| REVVITY, INC. | Health Technology |
| INSULET CORPORATION | Health Technology |
| THERMO FISHER SCIENTIFIC | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| Private Unternehmen | 11 |
|---|---|
Patheon, Inc.
 Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Finance |
Percivia LLC
Percivia LLC Miscellaneous Commercial ServicesCommercial Services Percivia LLC engages in the research and development of vaccine and recombinant protein products. The company was founded in 2006 and is headquartered in Cambridge, MA. | Commercial Services |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Health Technology |
| Biomedical Sciences Careers Program, Inc. | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade DPx Holdings BV provides pharmaceutical services, fine chemicals and proprietary products and technologies. It operates business through three business unites which include Patheon, DSM Fine Chemicals and Banner Life Sciences. Patheon consists of pharmaceutical services, which include commercial manufacturing capabilities, pharmaceutical development services, as well as the biologics and biosolutions businesses; DSM Fine Chemicals includes active pharmaceutical ingredients services as well as the ES/IM business offer is primarily comprised of agricultural and crop protection chemicals and specialty intermediates; and Banner Life Sciences serves the needs of the proprietary products business and will now include additional brands from DPP. The company has offices in Australia, Europe, Latin America and North America. DPx Holdings was founded in March 2014 and is headquartered in Framingham, MA. | Retail Trade |
Patheon NV
 Patheon NV Pharmaceuticals: MajorHealth Technology Patheon NV engages in the provision of pharmaceutical development and manufacturing services. It focuses on drug development, clinical trial logistics, and commercial manufacturing. The company was founded on December 24, 2013 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA. | Health Technology |
Vicarius Pharma AG
 Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Vicarius Pharma AG provides research and development services for pharmaceutical, biotech, and medical companies. The private company is based in Zurich, Switzerland. The Swiss company was founded by Hans-Peter Hasler. | Commercial Services |
